Unit of Periodontics, Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Department of Internal Medicine, PGIMER, Chandigarh, India.
J Dent Res. 2021 Feb;100(2):187-193. doi: 10.1177/0022034520970536. Epub 2020 Nov 2.
Understanding the pathophysiology of the coronavirus disease 2019 (COVID-19) infection remains a significant challenge of our times. The gingival crevicular fluid being representative of systemic status and having a proven track record of detecting viruses and biomarkers forms a logical basis for evaluating the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study aimed to assess gingival crevicular fluid (GCF) for evidence of SARS-CoV-2 in 33 patients who were deemed to be COVID-19 positive upon nasopharyngeal sampling. An attempt was also made to comparatively evaluate it with saliva in terms of its sensitivity, as a diagnostic fluid for SARS-CoV-2. GCF and saliva samples were collected from 33 COVID-19-confirmed patients. Total RNA was extracted using NucliSENS easyMAG (bioMérieux) and eluted in the elution buffer. Envelope gene ( gene) of SARS-CoV-2 and human RNase P gene as internal control were detected in GCF samples by using the TRUPCR SARS-CoV-2 RT qPCR kit V-2.0 (I) in an Applied Biosystems 7500 real-time machine. A significant majority of both asymptomatic and mildly symptomatic patients exhibited the presence of the novel coronavirus in their GCF samples. Considering the presence of SARS-CoV-2 RNA in the nasopharyngeal swab sampling as gold standard, the sensitivity of GCF and saliva, respectively, was 63.64% (confidence interval [CI], 45.1% to 79.60%) and 64.52% (CI, 45.37% to 80.77%). GCF was found to be comparable to saliva in terms of its sensitivity to detect SARS-CoV-2. Saliva samples tested positive in 3 of the 12 patients whose GCF tested negative, and likewise GCF tested positive for 2 of the 11 patients whose saliva tested negative on real-time reverse transcription polymerase chain reaction. The results establish GCF as a possible mode of transmission of SARS-CoV-2, which is the first such report in the literature, and also provide the first quantifiable evidence pointing toward a link between the COVID-19 infection and oral health.
了解 2019 年冠状病毒病(COVID-19)感染的病理生理学仍然是我们这个时代的重大挑战。牙龈沟液是系统性状态的代表,并且已经有检测病毒和生物标志物的可靠记录,这为评估严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)的存在提供了合理的依据。本研究旨在评估 33 名经鼻咽取样被认为 COVID-19 阳性的患者的牙龈沟液(GCF)中是否存在 SARS-CoV-2。还尝试将其与唾液进行比较,以评估其作为 SARS-CoV-2 诊断液的敏感性。从 33 名 COVID-19 确诊患者中采集 GCF 和唾液样本。使用 NucliSENS easyMAG(bioMérieux)提取总 RNA,并在洗脱缓冲液中洗脱。使用 TRUPCR SARS-CoV-2 RT qPCR 试剂盒 V-2.0(I)(Applied Biosystems 7500 实时机器)在 GCF 样本中检测 SARS-CoV-2 的包膜基因(基因)和人 RNA 聚合酶 P 基因作为内部对照。相当大比例的无症状和轻度症状患者的 GCF 样本中均存在新型冠状病毒。考虑到鼻咽拭子采样中 SARS-CoV-2 RNA 的存在作为金标准,GCF 和唾液的灵敏度分别为 63.64%(置信区间[CI],45.1%至 79.60%)和 64.52%(CI,45.37%至 80.77%)。就检测 SARS-CoV-2 的灵敏度而言,GCF 与唾液相当。在 12 名 GCF 检测阴性的患者中,有 3 名唾液样本检测阳性,同样在 11 名 GCF 检测阴性的患者中,有 2 名唾液样本检测阳性。实时逆转录聚合酶链反应。这些结果确立了 GCF 是 SARS-CoV-2 的一种可能传播方式,这是文献中的首次报道,也提供了 COVID-19 感染与口腔健康之间存在关联的首个可量化证据。